Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke.
Stroke stays a number one reason behind incapacity in america. Regardless of latest advances, interventions to scale back injury and improve restoration after stroke are missing. P2X4R, a receptor for adenosine triphosphate (ATP), regulates activation of myeloid immune cells (infiltrating monocytes/macrophages and brain-resident microglia) after stroke damage.
Nonetheless, over-stimulation of P2X4Rs on account of extreme ATP launch from dying or broken neuronal cells can contribute to ischemic damage. Subsequently, we pharmacologically inhibited P2X4R to restrict the over-stimulated myeloid cell immune response and enhance each acute and power stroke restoration. We subjected 8-12-week-old female and male wild sort mice to a 60 min proper center cerebral artery occlusion (MCAo) adopted by Three or 30 days of reperfusion.
We carried out histological, RNA sequencing, behavioral (sensorimotor, nervousness, and depressive), and biochemical (Evans blue dye extravasation, western blot, quantitative PCR, and circulation cytometry) analyses to find out the acute (Three days after MCAo) and power (30 days after MCAo) results of P2X4R antagonist 5-BDBD (1 mg/kg P.O. every day x Three days submit four h of MCAo) remedy.
5-BDBD remedy considerably (p < .05) diminished infarct quantity, neurological deficit (ND) rating, ranges of cytokine interleukin-1 beta (IL-1β) and blood mind barrier (BBB) permeability within the 3-day group.
) EIF3CL siRNA (Human) |
|||
| MBS8223624-15nmol | MyBiosource | 15nmol | EUR 405 |
EIF3CL siRNA (Human) |
|||
| MBS8223624-30nmol | MyBiosource | 30nmol | EUR 565 |
EIF3CL siRNA (Human) |
|||
| MBS8223624-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
) EIF3CL Antibody (N-term) |
|||
| E45R30984G-1 | EnoGene | 100 ul | EUR 395 |
EIF3CL Antibody (N-term) |
|||
| E45R30984G-4 | EnoGene | 50 ul | EUR 295 |
EIF3CL Antibody (N-term) |
|||
| MBS9205995-008mL | MyBiosource | 0.08mL | EUR 210 |
EIF3CL Antibody (N-term) |
|||
| MBS9205995-04mL | MyBiosource | 0.4mL | EUR 430 |
EIF3CL Antibody (N-term) |
|||
| MBS9205995-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
 Human EIF3CL shRNA Plasmid |
|||
| 20-abx968687 | Abbexa |
|
|
 Recombinant Human EIF3CL Protein |
|||
| E30P67027A | EnoGene | 50 ug | EUR 295 |
) EIF3CL Recombinant Protein (Human) |
|||
| RP056388 | ABM | 100 ug | Ask for price |
-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL)) EIF3CL (untagged)-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL) |
|||
| SC316845 | Origene Technologies GmbH | 10 µg | Ask for price |
 Rabbit pAb) EIF3CL (N-term) Rabbit pAb |
|||
| E2618440 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
 Rabbit pAb) EIF3CL (N-Term) Rabbit pAb |
|||
| MBS8556741-01mL | MyBiosource | 0.1mL | EUR 305 |
EIF3CL (N-Term) Rabbit pAb |
|||
| MBS8556741-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF3CL (N-Term) Rabbit pAb |
|||
| MBS8556741-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF3CL (N-Term) Rabbit pAb |
|||
| MBS8556741-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF3CL (N-Term) Rabbit pAb |
|||
| MBS8556741-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
 (pORF)) EIF3CL ORF Vector (Human) (pORF) |
|||
| ORF018797 | ABM | 1.0 ug DNA | EUR 486 |
 - Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL)) EIF3CL (GFP-tagged) - Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL) |
|||
| RG223143 | Origene Technologies GmbH | 10 µg | Ask for price |
 Human EIF3CL knockout cell line |
|||
| ABC-KH4695 | AcceGen | 1 vial | Ask for price |
|
Description: Human EIF3CL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
 Human EIF3CL knockdown cell line |
|||
| ABC-KD4695 | AcceGen | 1 vial | Ask for price |
|
Description: Human EIF3CL knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL)) EIF3CL (Myc-DDK-tagged)-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL) |
|||
| RC223143 | Origene Technologies GmbH | 10 µg | Ask for price |
 EIF3CL 3'UTR GFP Stable Cell Line |
|||
| TU056731 | ABM | 1.0 ml | EUR 1672.8 |
) EIF3CL sgRNA CRISPR Lentivector set (Human) |
|||
| K0667301 | ABM | 3 x 1.0 ug | EUR 406.8 |
 Blocking peptide) EIF3CL Antibody (N-term) Blocking peptide |
|||
| MBS9219264-INQUIRE | MyBiosource | INQUIRE | Ask for price |
 (pPM-C-HA)) EIF3CL Protein Vector (Human) (pPM-C-HA) |
|||
| PV075187 | ABM | 500 ng | EUR 973.2 |
-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL)) Lenti-ORF clone of EIF3CL (mGFP-tagged)-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL) |
|||
| RC223143L4 | Origene Technologies GmbH | 10 µg | Ask for price |
 (pPB-C-His)) EIF3CL Protein Vector (Human) (pPB-C-His) |
|||
| PV075185 | ABM | 500 ng | EUR 973.2 |
 (pPB-N-His)) EIF3CL Protein Vector (Human) (pPB-N-His) |
|||
| PV075186 | ABM | 500 ng | EUR 973.2 |
 (pPM-C-His)) EIF3CL Protein Vector (Human) (pPM-C-His) |
|||
| PV075188 | ABM | 500 ng | EUR 973.2 |
 EIF3CL 3'UTR Luciferase Stable Cell Line |
|||
| TU006731 | ABM | 1.0 ml | EUR 1672.8 |
-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL)) Lenti-ORF clone of EIF3CL (Myc-DDK-tagged)-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL) |
|||
| RC223143L3 | Origene Technologies GmbH | 10 µg | Ask for price |
-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL), 200ul, >10^7 TU/mL) Lenti ORF particles, EIF3CL (mGFP-tagged)-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL), 200ul, >10^7 TU/mL |
|||
| RC223143L4V | Origene Technologies GmbH | 200 µl | Ask for price |
 (Target 1)) EIF3CL sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0667302 | ABM | 1.0 ug DNA | EUR 184.8 |
 (Target 2)) EIF3CL sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0667303 | ABM | 1.0 ug DNA | EUR 184.8 |
 (Target 3)) EIF3CL sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0667304 | ABM | 1.0 ug DNA | EUR 184.8 |
-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL), 200ul, >10^7 TU/mL) Lenti ORF particles, EIF3CL (Myc-DDK-tagged)-Human eukaryotic translation initiation factor 3, subunit C-like (EIF3CL), 200ul, >10^7 TU/mL |
|||
| RC223143L3V | Origene Technologies GmbH | 200 µl | Ask for price |
 OAAB08888-400UL - EIF3CL Antibody - N-terminal region |
|||
| OAAB08888-400UL | Aviva Systems Biology | 400ul | EUR 389 |
 - 3 unique 27mer siRNA duplexes - 2 nmol each) EIF3CL (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR319023 | Origene Technologies GmbH | 2 nmol | Ask for price |
) EIF3CL sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0667305 | ABM | 3 x 1.0 ug | EUR 451.2 |
 (Target 1)) EIF3CL sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0667306 | ABM | 1.0 ug DNA | EUR 200.4 |
 (Target 2)) EIF3CL sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0667307 | ABM | 1.0 ug DNA | EUR 200.4 |
 (Target 3)) EIF3CL sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0667308 | ABM | 1.0 ug DNA | EUR 200.4 |
 EIF3CL - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL321053 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
 EIF3CL - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector |
|||
| TR321053 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
 ELISA Kit) Human Eukaryotic translation initiation factor 3 subunit C-like protein (EIF3CL) ELISA Kit |
|||
| abx521802-96tests | Abbexa | 96 tests | EUR 687.5 |
 for miRNA target validation) 3`UTR clone of eukaryotic translation initiation factor 3 subunit C-like (EIF3CL) for miRNA target validation |
|||
| SC202570 | Origene Technologies GmbH | 10 µg | Ask for price |
) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) |
|||
| MBS6002822-02mL | MyBiosource | 0.2(mL | EUR 695 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) |
|||
| MBS6002822-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
 (AP)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (AP) |
|||
| MBS6294995-02mL | MyBiosource | 0.2mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (AP) |
|||
| MBS6294995-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
 (PE)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (PE) |
|||
| MBS6295005-02mL | MyBiosource | 0.2mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (PE) |
|||
| MBS6295005-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
 (APC)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (APC) |
|||
| MBS6294996-02mL | MyBiosource | 0.2mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (APC) |
|||
| MBS6294996-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
 (Biotin)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (Biotin) |
|||
| MBS6294997-02mL | MyBiosource | 0.2mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (Biotin) |
|||
| MBS6294997-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
 (FITC)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (FITC) |
|||
| MBS6294998-02mL | MyBiosource | 0.2mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (FITC) |
|||
| MBS6294998-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
 (MaxLight 405)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 405) |
|||
| MBS6295000-01mL | MyBiosource | 0.1mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 405) |
|||
| MBS6295000-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
 (MaxLight 490)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 490) |
|||
| MBS6295001-01mL | MyBiosource | 0.1mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 490) |
|||
| MBS6295001-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
 (MaxLight 550)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 550) |
|||
| MBS6295002-01mL | MyBiosource | 0.1mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 550) |
|||
| MBS6295002-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
 (MaxLight 650)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 650) |
|||
| MBS6295003-01mL | MyBiosource | 0.1mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 650) |
|||
| MBS6295003-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
 (MaxLight 750)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 750) |
|||
| MBS6295004-01mL | MyBiosource | 0.1mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (MaxLight 750) |
|||
| MBS6295004-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
 (Azide free) (HRP)) EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (Azide free) (HRP) |
|||
| MBS6294999-02mL | MyBiosource | 0.2mL | EUR 980 |
EIF3CL, NT (EIF3C, EIF3S8, Eukaryotic translation initiation factor 3 subunit C, Eukaryotic translation initiation factor 3 subunit 8, eIF3 p110) (Azide free) (HRP) |
|||
| MBS6294999-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
, 0.5 ml each, >10^7 TU/ml.) EIF3CL - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml. |
|||
| TL321053V | Origene Technologies GmbH | 500 ul each | Ask for price |
 Eif3c/ Rat Eif3c ELISA Kit |
|||
| ELI-09630r | Lifescience Market | 96 Tests | EUR 1063.2 |
 (NM_003752) Human Recombinant Protein) eIF3s8 (EIF3C) (NM_003752) Human Recombinant Protein |
|||
| E45H34455M5 | EnoGene | 20 ug | EUR 785.42 |
 (NM_001037808) Human Recombinant Protein) eIF3s8 (EIF3C) (NM_001037808) Human Recombinant Protein |
|||
| E45H41275M5 | EnoGene | 20 ug | EUR 785.42 |
eIF3s8 (EIF3C) (NM_001037808) Human Recombinant Protein |
|||
| PROTQ99613 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human eukaryotic translation initiation factor 3, subunit C (EIF3C), transcript variant 2 |
|||
 EIF2C2 |
|||
| CSB-CL891731HU1 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
EIF2C2 |
|||
| CSB-CL891731HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
 EIF2C3 |
|||
| CSB-CL875700HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
EIF2C2 |
|||
| MBS8564154-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF2C2 |
|||
| MBS8564154-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF2C2 |
|||
| MBS8564154-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF2C2 |
|||
| MBS8564154-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EIF2C2 |
|||
| MBS8564154-02mL | MyBiosource | 0.2mL | EUR 345 |
 (NM_003752) Human Over-expression Lysate) eIF3s8 (EIF3C) (NM_003752) Human Over-expression Lysate |
|||
| E45H19145-2 | EnoGene | 20 ug | EUR 395 |
 (NM_001037808) Human Over-expression Lysate) eIF3s8 (EIF3C) (NM_001037808) Human Over-expression Lysate |
|||
| E45H04551-2 | EnoGene | each | EUR 395 |
eIF3s8 (EIF3C) (NM_003752) Human Over-expression Lysate |
|||
| LS008663 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of eukaryotic translation initiation factor 3, subunit C (EIF3C), transcript variant 1 |
|||
 - Rat eukaryotic translation initiation factor 2C, 4 (Eif2c4), (10 ug)) Eif2c4 (untagged ORF) - Rat eukaryotic translation initiation factor 2C, 4 (Eif2c4), (10 ug) |
|||
| RN215671 | Origene Technologies GmbH | 10 µg | Ask for price |
 - Rat eukaryotic translation initiation factor 2C, 2 (Eif2c2), (10 ug)) Eif2c2 (untagged ORF) - Rat eukaryotic translation initiation factor 2C, 2 (Eif2c2), (10 ug) |
|||
| RN210245 | Origene Technologies GmbH | 10 µg | Ask for price |
 EIF2C1 Peptide |
|||
| 45-525P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: EIF2C1 Peptide |
|||
 EIF2C3 Rabbit mAb |
|||
| 59065 | SAB | 100ul | EUR 339 |
 eIF2C3 Rabbit mAb |
|||
| A19819 | Abclonal | 50μL | EUR 828.95 |
|
Description: A synthetic peptide corresponding to a sequence within amino acids 100-200 of human HTRA2 (O43464). |
|||
 EIF2C3 cDNA Clone |
|||
| MBS1272797-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 200 |
EIF2C3 cDNA Clone |
|||
| MBS1272797-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 855 |
 EIF2C2 cDNA Clone |
|||
| MBS1270348-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 200 |
EIF2C2 cDNA Clone |
|||
| MBS1270348-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 855 |
EIF2C2 cDNA Clone |
|||
| MBS1275868-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 565 |
EIF2C2 cDNA Clone |
|||
| MBS1275868-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 2510 |
 EIF2C3 Rabbit pAb |
|||
| E2381362 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
 eIF2C2 Rabbit mAb |
|||
| E38A4285 | EnoGene | 100ug/100ul | EUR 255 |
eIF2C3 Rabbit mAb |
|||
| E38A4286 | EnoGene | 100ug/100ul | EUR 255 |
 EIF2C2 Rabbit pAb |
|||
| E2506802 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
EIF2C2 Rabbit pAb |
|||
| E2510968 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
eIF2C3 Rabbit mAb |
|||
| E45R11732N | EnoGene | 50 ul | EUR 346.5 |
EIF2C3 Rabbit pAb |
|||
| MBS8542826-01mL | MyBiosource | 0.1mL | EUR 305 |
EIF2C3 Rabbit pAb |
|||
| MBS8542826-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF2C3 Rabbit pAb |
|||
| MBS8542826-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF2C3 Rabbit pAb |
|||
| MBS8542826-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF2C3 Rabbit pAb |
|||
| MBS8542826-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8546380-01mL | MyBiosource | 0.1mL | EUR 305 |
EIF2C2 Rabbit pAb |
|||
| MBS8546380-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8546380-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8546380-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8546380-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8548254-01mL | MyBiosource | 0.1mL | EUR 305 |
EIF2C2 Rabbit pAb |
|||
| MBS8548254-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8548254-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8548254-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF2C2 Rabbit pAb |
|||
| MBS8548254-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
 - Rat eukaryotic translation initiation factor 2C, 2 (Eif2c2), 200ul, >10^7 TU/mL) Lenti ORF particles, Eif2c2 (GFP-tagged ORF) - Rat eukaryotic translation initiation factor 2C, 2 (Eif2c2), 200ul, >10^7 TU/mL |
|||
| RR210245L4V | Origene Technologies GmbH | 200 µl | Ask for price |
 - Rat eukaryotic translation initiation factor 2C, 4 (Eif2c4), 200ul, >10^7 TU/mL) Lenti ORF particles, Eif2c4 (GFP-tagged ORF) - Rat eukaryotic translation initiation factor 2C, 4 (Eif2c4), 200ul, >10^7 TU/mL |
|||
| RR215671L4V | Origene Technologies GmbH | 200 µl | Ask for price |
 - Rat eukaryotic translation initiation factor 2C, 2 (Eif2c2), (10 ug)) Eif2c2 (Myc-DDK-tagged ORF) - Rat eukaryotic translation initiation factor 2C, 2 (Eif2c2), (10 ug) |
|||
| RR210245 | Origene Technologies GmbH | 10 µg | Ask for price |
 - Rat eukaryotic translation initiation factor 2C, 4 (Eif2c4), (10 ug)) Eif2c4 (Myc-DDK-tagged ORF) - Rat eukaryotic translation initiation factor 2C, 4 (Eif2c4), (10 ug) |
|||
| RR215671 | Origene Technologies GmbH | 10 µg | Ask for price |
 (AP)) AGO1 (Argonaute RISC Catalytic Component 1, Q99, EIF2C, EIF2C1, GERP95) (AP) |
|||
| MBS6405794-01mL | MyBiosource | 0.1mL | EUR 950 |
AGO1 (Argonaute RISC Catalytic Component 1, Q99, EIF2C, EIF2C1, GERP95) (AP) |
|||
| MBS6405794-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
 (PE)) AGO1 (Argonaute RISC Catalytic Component 1, Q99, EIF2C, EIF2C1, GERP95) (PE) |
|||
| MBS6405804-01mL | MyBiosource | 0.1mL | EUR 950 |
AGO1 (Argonaute RISC Catalytic Component 1, Q99, EIF2C, EIF2C1, GERP95) (PE) |
|||
| MBS6405804-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
 EIF2C1 antibody |
|||
| 70R-21524 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal EIF2C1 antibody |
|||
 EIF2C3 antibody |
|||
| 70R-2539 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal EIF2C3 antibody raised against the N terminal of EIF2C3 |
|||
 EIF2C4 antibody |
|||
| 70R-3041 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal EIF2C4 antibody raised against the middle region of EIF2C4 |
|||
EIF2C1 antibody |
|||
| 70R-3471 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal EIF2C1 antibody raised against the N terminal of EIF2C1 |
|||
 EIF2C2 antibody |
|||
| 70R-17042 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal EIF2C2 antibody |
|||
 Eif2c3 antibody |
|||
| 70R-9606 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Affinity purified rabbit polyclonal Eif2c3 antibody |
|||
 EIF2C3 Antibody |
|||
| ABD9508 | Lifescience Market | 100 ug | EUR 525.6 |
 EIF2C1 Antibody |
|||
| 39951-100ul | SAB | 100ul | EUR 468 |
EIF2C3 Antibody |
|||
| 39952-100ul | SAB | 100ul | EUR 468 |
EIF2C3 Antibody |
|||
| DF9508 | Affbiotech | 200ul | EUR 420 |
EIF2C3 Antibody |
|||
| DF9508-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,IHC,ELISA(peptide) |
|||
EIF2C3 Antibody |
|||
| DF9508-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,IHC,ELISA(peptide) |
|||
 EIF2C4 Antibody |
|||
| GWB-MV390C | GenWay Biotech | 50ug | Ask for price |
 Eif2c3 Antibody |
|||
| GWB-MV397A | GenWay Biotech | 50ug | Ask for price |
EIF2C3 Antibody |
|||
| GWB-MV398B | GenWay Biotech | 50ug | Ask for price |
EIF2C1 Antibody |
|||
| GWB-MT589D | GenWay Biotech | 50ug | Ask for price |
EIF2C1 Antibody |
|||
| E301712b | EnoGene | 100ug/200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
EIF2C3 Antibody |
|||
| E301713 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
 EIF2C2 Antibody |
|||
| E312331 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
EIF2C1 antibody |
|||
| E39-10769 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
EIF2C3 Antibody |
|||
| E19-9508-1 | EnoGene | 50ug/50ul | EUR 145 |
|
Description: Available in various conjugation types. |
|||
EIF2C3 Antibody |
|||
| E19-9508-2 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
EIF2C3 Antibody |
|||
| MBS9609825-01mL | MyBiosource | 0.1mL | EUR 260 |
EIF2C3 Antibody |
|||
| MBS9609825-02mL | MyBiosource | 0.2mL | EUR 305 |
EIF2C3 Antibody |
|||
| MBS9609825-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
EIF2C3 Antibody |
|||
| MBS8518519-005mg | MyBiosource | 0.05mg | EUR 235 |
EIF2C3 Antibody |
|||
| MBS8518519-01mg | MyBiosource | 0.1mg | EUR 305 |
EIF2C3 Antibody |
|||
| MBS8518519-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
EIF2C3 Antibody |
|||
| MBS8518519-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
EIF2C3 Antibody |
|||
| MBS8518519-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
EIF2C1 Antibody |
|||
| MBS8526929-01mg | MyBiosource | 0.1mg | EUR 345 |
EIF2C1 Antibody |
|||
| MBS8526929-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF2C1 Antibody |
|||
| MBS8526929-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF2C1 Antibody |
|||
| MBS8526929-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF2C1 Antibody |
|||
| MBS8526929-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EIF2C3 Antibody |
|||
| MBS8526930-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EIF2C3 Antibody |
|||
| MBS8526930-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EIF2C3 Antibody |
|||
| MBS8526930-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EIF2C3 Antibody |
|||
| MBS8526930-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EIF2C3 Antibody |
|||
| MBS8526930-02mL | MyBiosource | 0.2mL | EUR 345 |
EIF2C1 Antibody |
|||
| MBS9410256-01mL | MyBiosource | 0.1mL | EUR 420 |
EIF2C1 Antibody |
|||
| MBS9410256-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
EIF2C3 Antibody |
|||
| MBS9414316-01mL | MyBiosource | 0.1mL | EUR 420 |
EIF2C3 Antibody |
|||
| MBS9414316-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
 (HRP)) AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (HRP) |
|||
| MBS6244111-01mL | MyBiosource | 0.1(mL | EUR 965 |
AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (HRP) |
|||
| MBS6244111-5x01mL | MyBiosource | 5x0.1mL | EUR 4200 |
 (PE)) AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (PE) |
|||
| MBS6244644-01mL | MyBiosource | 0.1(mL | EUR 965 |
AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (PE) |
|||
| MBS6244644-5x01mL | MyBiosource | 5x0.1mL | EUR 4200 |
 (APC)) AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (APC) |
|||
| MBS6242513-01mL | MyBiosource | 0.1(mL | EUR 965 |
AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (APC) |
|||
| MBS6242513-5x01mL | MyBiosource | 5x0.1mL | EUR 4200 |
 (FITC)) AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (FITC) |
|||
| MBS6243578-01mL | MyBiosource | 0.1(mL | EUR 965 |
AGO3 (Protein Argonaute-3, Argonaute3, hAgo3, Eukaryotic Translation Initiation Factor 2C 3, eIF-2C 3, eIF2C 3, EIF2C3) (FITC) |
|||
| MBS6243578-5x01mL | MyBiosource | 5x0.1mL | EUR 4200 |
Chronically, 5-BDBD remedy additionally conferred progressive restoration (p < .05) of motor stability and coordination utilizing a rotarod take a look at, in addition to diminished anxiety-like conduct over 30 days. Curiously, depressive-type conduct was not noticed in mice handled with 5-BDBD for Three days. As well as, circulation cytometric evaluation revealed that 5-BDBD remedy decreased the overall variety of infiltrated leukocytes, and amongst these infiltrated leukocytes, pro-inflammatory cells of myeloid origin have been particularly diminished. 5-BDBD remedy diminished the cell floor expression of P2X4R in circulation cytometry-sorted monocytes and microglia with out lowering the overall P2X4R stage in mind tissue.
In abstract, acute P2X4R inhibition protects towards ischemic damage at each acute and power time-points after stroke. Diminished numbers of infiltrating pro-inflammatory myeloid cells, decreased floor P2X4R expression, and diminished BBB disruption are seemingly its mechanism of neuroprotection and neuro-rehabilitation.
